Terry Dagnon
2020
In 2020, Terry Dagnon earned a total compensation of $159.7K as Chief Operating Officer at Outlook Therapeutics.
Compensation breakdown
| Other | $159,677 |
|---|---|
| Total | $159,677 |
Dagnon received $159.7K in other compensation, accounting for 100% of the total pay in 2020.
Rankings
In 2020, Terry Dagnon's compensation ranked 12,728th out of 13,090 executives tracked by ExecPay. In other words, Dagnon earned more than 2.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,728 out of 13,090 | 3rd |
Division Manufacturing | 5,457 out of 5,621 | 3rd |
Major group Chemicals And Allied Products | 2,201 out of 2,254 | 2nd |
Industry group Drugs | 1,912 out of 1,954 | 2nd |
Industry Biological Products, Except Diagnostic Substances | 406 out of 411 | 1st |
Source: SEC filing on February 22, 2021.
Dagnon's colleagues
We found two more compensation records of executives who worked with Terry Dagnon at Outlook Therapeutics in 2020.
News
Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
February 8, 2024
Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
February 15, 2023
Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
January 27, 2022
Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
February 22, 2021